Evaluating Neostigmine Effect on Reducing Gastric Residual Volume as Compared With Metoclopramide and Ondansetron

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 15, 2022

Primary Completion Date

July 30, 2022

Study Completion Date

October 17, 2022

Conditions
Delayed Gastric Emptying
Interventions
DRUG

Neostigmine

will be given by infusion in 20 minutes once daily by a nurse blinded to the study drugs

DRUG

Ondansetron 8mg

will be given by infusion in 20 minutes once daily by a nurse blinded to the study drugs

DRUG

Metoclopramide Injection

will be given by infusion in 20 minutes once daily by a nurse blinded to the study drugs

OTHER

Enteral feeding nutrition

The type and rate of enteral feeding nutrition will be the same for all patients (180ml/3h). All patients have a 30-degree head-up position

OTHER

Sequential Organ Failure Assessment (SOFA) score

SOFA score will be performed on all patients before the beginning of the study

Trial Locations (1)

000000

Sharurah Armed Forces Hospital, Sharurah

All Listed Sponsors
lead

Tanta University

OTHER